Search results
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 18 hours agoPharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 16 hours agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
US opens COVID vaccine to little kids, shots begin next week
AOL· 2 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 1 day agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 2 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19 ...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 3 days agoAccording to mounting data, one of the more serious side effects of the COVID mRNA jabs appears to be dementia, and worse yet, this previously ...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 3 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 2 days agoAll participants received two doses of 10mcg Pfizer/BioNTech mRNA COVID-19 vaccination, 21 days apart. The team followed up with the participants for one ...
Cancer breakthrough as scientists develop jab that could provide miracle cure
Daily Express· 6 days agoA revolutionary skin cancer vaccine being tested on British patients offers hope of a cure for the...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
Digital Journal· 2 days agoThe Phase 1 clinical trial, protocol number KM-NVCoV2-001, which received approval from the regulatory agency in India for healthy as well as COVID-19 participants, was closed ...